3D print-on-demand technology for personalised medicines at the point of care

用于护理点个性化药物的 3D 按需打印技术

• 批准号: 10045111
• 金额: $ 5.85万
• 依托单位: DELTA PHARMACEUTICS LIMITED
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10045111
• 关键词: 3D; print; demand; technology; personalised

The aim of the project is to develop a 3D printing technology that can be used to print on demand medicines (e.g., tablets, or complex designs) which are suitable for individual patients. This platform technology will allow the printing of various compounding drugs at the hospital where the dose can be printed at different strengths and high accuracy.These personalised medications will offer treatment specifically designed to suit the unique needs of the patients and improve their wellbeing. The printed tablets or capsules dissolve rapidly when placed on the patient tongue and provide an appealing taste through the incorporation of flavours and sweeteners. The technology offers efficient taste masking of bitter drugs and hence improve the medicine acceptability from children. It will be also suitable for geriatric patients especially those with swallowing difficulties (e.g., stroke, dementia) or have stomach pathologies.Most importantly this novel technology will be cost-effective, print medicines in short times, reduce medication wastage and increase the effectiveness of healthcare. The use of 3D printing technologies at the hospital will allow clinicians to design, print and distribute compounding drugs for improved patient treatment.

该项目的目的是开发一种3D打印技术，可用于按需打印药物（例如，片剂或复杂的设计），其适合于个体患者。该平台技术将允许在医院打印各种复合药物，可以以不同的强度和高精度打印剂量。这些个性化药物将提供专门设计的治疗，以满足患者的独特需求，并改善他们的健康。当置于患者舌头上时，印刷的片剂或胶囊迅速溶解，并通过掺入香料和甜味剂提供吸引人的味道。该技术提供了对苦味药物的有效掩味，从而提高了儿童对药物的可接受性。它也适用于老年患者，特别是吞咽困难的患者（例如，中风、痴呆症）或患有胃病。最重要的是，这项新技术具有成本效益，可以在短时间内打印药物，减少药物浪费并提高医疗保健的有效性。在医院使用3D打印技术将使临床医生能够设计，打印和分发复合药物，以改善患者治疗。